Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 122 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
27 Aug 2024
10% owner indirect
Sold at will
51,630
$108.86K
4.7%
23 Aug 2024
10% owner indirect
Sold at will
40,000
$91.42K
3.5%
24 Jun 2024
VP, Clinical Trial Operations
Sold at will
6,849
$14.52K
38.7%
24 Jun 2024
General Counsel
Sold at will
5,496
$11.65K
22.1%
24 Jun 2024
Head of Quality
Sold at will
4,961
$10.52K
23.5%
29 May 2024
Director
Bought
6,250
no price
181%
29 May 2024
Director
Bought
6,250
no price
90.3%
29 May 2024
Director
Bought
2,500
no price
0.5%
29 May 2024
Director
Bought
8,000
no price
179%
29 May 2024
VP, Clinical Trial Operations
Bought
2,500
no price
opened
29 May 2024
President and CEO indirect
Bought
200,000
no price
opened
29 May 2024
Head of Regulatory
Bought
1,250
no price
10.4%
29 May 2024
General Counsel
Bought
10,000
no price
×17
29 May 2024
Chief Financial Officer
Bought
31,250
no price
opened
15 May 2024
10% owner indirect
Sold at will
17,094
$62.62K
1.5%
14 May 2024
10% owner indirect
Sold at will
15,426
$55.27K
1.3%
13 May 2024
10% owner indirect
Sold at will
3,446
$12.48K
0.3%
8 May 2024
10% owner indirect
Sold at will
13,919
$53.19K
1.2%
7 May 2024
10% owner indirect
Sold at will
6,025
$22.11K
0.5%
1 May 2024
10% owner indirect
Sold at will
33,061
$109.16K
2.7%
30 Apr 2024
10% owner indirect
Sold at will
20,535
$63.98K
1.6%
29 Apr 2024
10% owner indirect
Sold at will
6,403
$20.79K
0.5%
24 Apr 2024
10% owner indirect
Sold at will
8,064
$28.25K
0.6%
23 Apr 2024
10% owner indirect
Sold at will
22,000
$76.80K
1.7%
22 Apr 2024
10% owner indirect
Sold at will
14,331
$50.60K
1.1%
17 Apr 2024
10% owner indirect
Sold at will
22,737
$84.42K
1.7%
16 Apr 2024
10% owner indirect
Sold at will
48,683
$171.80K
3.5%
15 Dec 2023
VP, Clinical Trial Operations
Sold at will
32,535
$428.18K
100%
13 Dec 2023
Director
Sold at will
9,000
$120.39K
1.9%
13 Dec 2023
Director
Sold at will
9,000
$118.97K
72.2%
7 Dec 2023
VP, Clinical Trial Operations
Sold at will
36,800
$436.00K
53.1%
21 Nov 2023
VP, Clinical Trial Operations
Sold at will
18,665
$191.56K
21.2%
20 Nov 2023
VP, Clinical Trial Operations
Sold at will
14,594
$164.26K
14.2%
17 Nov 2023
VP, Clinical Trial Operations
Sold at will
3,541
$46.17K
3.3%
25 Oct 2023
10% owner indirect
Sold at will
5,704
$110.64K
0.4%
24 Oct 2023
VP, Clinical Trial Operations
Sold at will
5,200
$99.35K
4.7%
23 Oct 2023
10% owner indirect
Sold at will
49,987
$998.37K
3.5%
16 Oct 2023
Director
Sold at will
3,333
$69.04K
0.7%
10 Oct 2023
VP, Clinical Trial Operations
Sold at will
5,200
$114.46K
4.7%
5 Oct 2023
10% owner indirect
Sold at will
14,251
$355.23K
1.0%
3 Oct 2023
10% owner indirect
Sold at will
75,690
$1.93M
5.0%
28 Sep 2023
10% owner indirect
Sold at will
2,289
$55.21K
0.2%
27 Sep 2023
10% owner indirect
Sold at will
11,257
$275.46K
0.7%
26 Sep 2023
10% owner indirect
Sold at will
29,805
$709.18K
1.9%
26 Sep 2023
VP, Clinical Trial Operations
Sold at will
5,200
$122.53K
4.7%
25 Sep 2023
10% owner indirect
Sold at will
12,458
$321.00K
0.8%
22 Sep 2023
10% owner indirect
Sold at will
9,042
$247.12K
0.6%
21 Sep 2023
10% owner indirect
Sold at will
7,549
$214.88K
0.5%
20 Sep 2023
General Counsel
Sold at will
10,000
$300.00K
94.6%
20 Sep 2023
VP, Clinical Trial Operations
Sold at will
6,000
$167.79K
5.4%
Showing 51–100 of 122. ← Newer Page 2 of 3 Older →